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Here we provide evidence for a critical role of PP2As (protein
phosphatase 2As) in the transformation of Trypanosoma cruzi. In
axenic medium at pH 5.0, trypomastigotes rapidly transform into
amastigotes, a process blocked by okadaic acid, a potent PP2A
inhibitor, at concentrations as low as 0.1 µM. 1-Norokadaone, an
inactive okadaic acid analogue, did not affect the transformation.
Electron microscopy studies indicated that okadaic acid-treated
trypomastigotes had not undergone ultrastructural modifications,
reinforcing the idea that PP2A inhibits transformation. Using
a microcystin–Sepharose affinity column we purified the native
T. cruzi PP2A. The enzyme displayed activity against 32P-labelled
phosphorylase a that was inhibited in a dose-dependent manner
by okadaic acid. The protein was also submitted to MS and,
from the peptides obtained, degenerate primers were used to
clone a novel T. cruzi PP2A enzyme by PCR. The isolated gene
encodes a protein of 303 amino acids, termed TcPP2A, which
displayed a high degree of homology (86%) with the catalytic
subunit of Trypanosoma brucei PP2A. Northern-blot analysis
revealed the presence of a major 2.1-kb mRNA hybridizing in all
T. cruzi developmental stages. Southern-blot analysis suggested
that the TcPP2A gene is present in low copy number in the
T. cruzi genome. These results are consistent with the mapping
of PP2A genes in two chromosomal bands by pulsed-field gel
electrophoresis and chromoblot hybridization. Our studies sug-
gest that in T. cruzi PP2A is important for the complete trans-
formation of trypomastigotes into amastigotes during the life
cycle of this protozoan parasite.
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INTRODUCTION
Trypanosoma cruzi is the causative agent of Chagas’ disease that
affects 16–18 million people in Latin America. The infection is
initiated by metacyclic trypomastigotes present in the faeces of
triatomine bugs. Trypomastigotes invade vertebrate host cells and
immediately come into contact with the lysosomal compartment
[1]. The acidic milieu of lysosomes induces the transformation
of trypomastigotes into amastigotes [2], which replicate free in
the cytoplasm and a few days later transform back into try-
pomastigotes that are released into the bloodstream after rupturing
the host cell. Thus on two occasions during its intracellular de-
velopment, T. cruzi undergoes dramatic changes in cellular shape
and volume, restructures its flagellum and kinetoplast, and syn-
thesizes new sets of surface molecules. These striking modifi-
cations are precisely timed, take place in an orderly fashion, and
must involve specific proteolytic and signalling pathways.
Little is known about the signals and molecular mechanisms
involved in trypanosome differentiation and proliferation. It was
shown previously that T. cruzi transformation is proteasome-
dependent [3]. Like other eukaryotes, protein phosphorylation and
signal transduction pathways are associated with the control of
this complex process in trypanosomes [4]. In higher eukaryotes,
the reversible phosphorylation of proteins (on serine, threonine
and tyrosine residues) plays a key role in the integration of
signals involved in cellular proliferation and differentiation [5,6].
Similar regulatory pathways also exist in T. cruzi and could be in-
Abbreviations used: DMEM, Dulbecco’s modified Eagle’s medium; DMSO, dimethyl sulphoxide; mAb, monoclonal antibody; PFGE, pulsed-field gel
electrophoresis; PP, protein phosphatase; PP2Ac, catalytic subunit of PP2A; Tos-Lys-CH2Cl, tosyl-lysylchloromethane; Q-TOF, quadrupole time-of-flight.
1 To whom correspondence should be addressed (e-mail jgonzalez@uantof.cl).
The nucleotide sequences data reported are available in the GenBank® Nucleotide Sequence Database under the accession numbers AF510320 and
AY158228.
volved in parasite differentiation. cAMP, an important second
messenger in higher eukaryotes, has been reported to be in-
volved in the transformation of the epimastigote to metacyclic
trypomastigote in the insect vector [7], and in the control of
proliferation and differentiation of amastigotes [8]. Several serine/
threonine protein kinase activities, including protein kinase A
[9], protein kinase C [10] and a calcium- and calmodulin-
dependent protein kinase [11], have been detected in T. cruzi
epimastigotes. However, information about serine/threonine PPs
(protein phosphatases) in this organism is limited to the report of
two type 1 PPs [12].
In eukaryotic cells, four major classes of PP have been
identified: PP1, PP2A, PP2B and PP2C [6,13,14]. This classi-
fication is based on the use of specific activators and inhibitors,
the substrate specificity and the bivalent cation requirements
of these enzymes. Subsequent amino acid and cDNA sequencing
studies have revealed that PP1, PP2A and PP2B are members
of the same gene family, termed the PPP family, which share a
conserved catalytic core of approx. 280 amino acids [13]. On the
other hand, PP2C is structurally and mechanistically unrelated to
the PPP family and has been classified as a member of the PPM
family of Mg2+-dependent PPs.
In mammalian cells, PP2A is a major protein serine/threonine
phosphatase that plays an important role in processes regulated
by reversible protein phosphorylation [5,15,16]. PP2A exists
as holoenzymes: the basic structure contains an invariant core
dimer that is composed of a highly conserved 36-kDa catalytic
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subunit (PP2Ac) tightly bound to a 65-kDa regulatory subunit
(PR65/A). PR65/A acts as a scaffold protein for the binding
of PP2Ac and a large number of B-type regulatory subunits in
the heterotrimeric holoenzyme [15,16]. The three major families
of B-type regulatory subunits, PR55/B [17], PR61/B′ [18] and
PR72/B′ ′ [19] share no significant similarity in primary structure.
This diversity is believed to determine the enzymic activity and
substrate specificity of PP2Ac, as well as intracellular localization
and tissue specificity of distinct holoenzyme forms [5,16].
The experiments described below were designed to show the
presence and involvement of PP2A in the developmental pathways
of the human protozoan parasite T. cruzi. One practical advan-
tage of this organism as an experimental model is that try-
pomastigote forms can be induced to change rapidly into the
amastigote form in axenic medium. The resulting amastigote-like
parasites cannot be distinguished from intracellular amastigotes
by light or electron microscopy, or by stage-specific surface
markers. Thus in this model, the effect of phosphatase inhibitors
on transformation can be studied independently of their effect on
the host cells.
EXPERIMENTAL
Material and reagents
Kinase and phosphatase inhibitors were purchased from
Calbiochem (La Jolla, CA, U.S.A.) except as otherwise noted.
Staurosporin and genistein were from Sigma (St. Louis, MO,
U.S.A.).
Inhibition of transformation of trypomastigotes into amastigotes
T. cruzi (G strain) epimastigotes and metacyclic trypomastigotes
were grown at 28 ◦C in liver-infusion tryptose broth as described
previously [3]. Metacyclic trypomastigotes were separated from
residual epimastigotes by anion-exchange chromatography [20].
Vero cells were infected with trypomastigotes as described
previously [3]. Then, 5 days later, supernatants contained more
than 95% trypomastigotes that were collected by centrifugation.
Trypomastigote transformation into amastigotes was induced as
reported previously [2]. To assay the effect of kinase and phos-
phatase inhibitors on T. cruzi transformation, 2-fold dilutions of
each inhibitor were distributed in 96-microwell plates. Dilutions
were made with DMEM (Dulbecco’s modified Eagle’s medium)
buffered with 20 mM Mes (pH 5.0) containing 0.4% BSA. All
inhibitors were dissolved in DMSO at 200 µM and added to wells
to final concentrations of 0.1–10 µM. Trypomastigotes were cen-
trifuged (3000 g for 10 min) and resuspended at 2 ×107/ml in
DMEM (pH 5.0); 50 µl of this suspension were added to each
well, mixed and incubated for 4 h at 37 ◦C in an atmosphere
containing 5%CO2. The percentage of transformed parasites was
estimated by microscopically scoring 250 cells in each well in a
blinded fashion. All experiments were carried out in triplicate.
Microcystin affinity purification of T. cruzi PP2A
PP2A purification was performed according to Collins and Sim
[21], with slight modifications. Briefly, epimastigotes from 7-day
cultures (late logarithmic phase) were collected by centrifugation
at 2000 g for 20 min and washed three times with Tris-
buffered saline. The pellet was then resuspended in 5 vol. of
buffer A (50 mM triethanolamine, 0.3 mM EGTA, 5% glycerol,
0.5 M NaCl, 1 mM MnCl2 and 0.1 mM dithiothreitol, pH 7.5)
containing a mixture of protease inhibitors [25 µg/ml E-64,
25 µg/ml leupeptin, 1 mM benzamidine, 1 mM PMSF, 0.5 mM
Tos-Lys-CH2Cl (tosyl-lysylchloromethane, or ‘TLCK’), 10 µg/
ml soya bean trypsin inhibitor, 0.1 µg/ml aprotinin and 2 µg/ml
pepstatin A] and lysed by 10 cycles of freezing in liquid N2 and
thawing at 30 ◦C. The homogenate was clarified by centrifugation
for 15 min at 8000 g, and the supernatant was centrifuged at
100 000 g for 1 h. The supernatant was filtered in acrodisc
0.45 µm (Gelman, Ann Arbor, MI, U.S.A.), poured into a column
containing 0.5 ml of microcystin–Sepharose (Upstate Biotech-
nology, Lake Placid, NY, U.S.A.) and incubated under gentle
agitation for 4 h at 4 ◦C. The column was washed extensively with
buffer A containing 1 M NaCl and 0.5 mM MnCl2, followed by
incubation at 4 ◦C for 2 h with 3 M KSCN in buffer A and 0.5 mM
MgCl2. The bound phosphatase was eluted in the same buffer and
dialysed immediately against buffer A containing 150 mM NaCl
and 0.5 mM MgCl2.
Immunoprecipitation studies
For immunoprecipitation studies a native PP2A was purified as
described above, where parasites were harvested from 35 l of
a 6-day-old T. cruzi epimastigote culture. The purified protein
was immunoprecipitated as described previously [3] using a
commercial mAb (monoclonal antibody) raised against the cata-
lytic domain of human PP2A (Transduction Laboratories, San
Diego, CA, U.S.A.). The immunocomplexes were collected by
incubation with 100 µl of a 50% suspension of Protein G–
Sepharose (Amersham Biosciences, Piscataway, NJ, U.S.A.). The
immunoprecipitates were washed and PP2A activity measured in
the presence or absence of PP inhibitors. In order to demostrate
that native protein was recognized by the mAb, it was separated by
SDS/PAGE, transferred to PVDF membrane (Bio-Rad, Hercules,
CA, U.S.A.), blocked with PBS containing 5% skimmed milk
and incubated with mAb against human PP2A or an unrelated
mAb (25A10, raised against T. cruzi proteasome), for 1 h at room
temperature. After several washes in PBS containing 0.05%
Tween 20, the membrane was incubated with anti-mouse IgG
conjugated with peroxidase. The final reaction was revealed
by chemiluminescence using an ECL Western-blotting detection
reagent (Amersham Biosciences, Piscataway, NJ, U.S.A.). For co-
immunoprecipitation with cytoskeletal proteins, trypomastigotes
were dissolved in ice-cold lysis buffer (25 mM Tris, 150 mM
NaCl, 0.5% Nonidet P40, 5 mM EGTA, 25 µg/ml E-64,
25 µg/ml leupeptin, 1 mM benzamidine, 1 mM PMSF, 0.5 mM
Tos-Lys-CH2Cl, 10 µg/ml soya bean trypsin inhibitor, 0.1 µg/ml
aprotinin and 2 µg/ml pepstatin A) and incubated for 30 min
at 4 ◦C. After centrifugation the supernatant was pre-cleared by
incubation with an excess of Protein G–Sepharose. Immuno-
precipitation was performed as described above, using commer-
cial mAb raised against α-tubulin, actin and myosin (Sigma). The
immunoprecipitates were washed and PP2A activity measured in
the presence or absence of PP inhibitors.
Protein determination and SDS/PAGE
Protein concentration was determined using the Bio-Rad protein
assay (Bio-Rad). Samples were separated by SDS/PAGE ac-
cording to [22] in 3% stacking and 12% separating gels, and
silver stained as described in [23]. Bands were cut and submitted
to MS.
Identification of native PP2A by MS analysis
The analysis was performed in the Protein Analysis Facility,
Skirball Institute of Biomolecular Medicine (New York University
c© 2003 Biochemical Society
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School of Medicine, NY, U.S.A.), as reported previously [24].
The resulting peptide mixture was analysed by nanoelectrospray
tandem MS in a Q-TOF (quadrupole time-of-flight) mass spec-
trometer (Micromass, Beverly, MA, U.S.A.). The amino acid
sequences obtained in this way were searched against the NCBI
non-redundant protein database using the BLAST search program
[25].
Phospho-immunoblot analysis of cytoskeletal proteins in the
flagellar fraction of T. cruzi
In a standard experiment, 1×107 trypomastigotes were incubated
at 37 ◦C in DMEM in the presence or absence of okadaic acid
or 1-norokadaone, and aliquots were taken at time 0 (pH 7.2)
and 0.5, 1, 2, 3 and 4 h later in transformation medium (pH 5.0).
The parasites were centrifuged and the cytoskeletal fraction was
extracted from the pellets as described previously [26]. Briefly,
pellets were incubated at 4 ◦C in buffer containing phosphatase
and protease inhibitors (60 mM Pipes, 25 mM Hepes, pH 7.4,
10 mM EGTA, 2 mM MgCl2, 0.5%Triton X-100, 25 µg/ml anti-
pain, 25 µg/ml E-64, 25 µg/ml leupeptin, 1 mM benzamidine,
1 mM PMSF, 0.5 mM Tos-Lys-CH2Cl, 10 µg/ml aprotinin, 2 µg/
ml pepstatin A, 1 mM iodoacetamide, 2.5 mM NaVO4, 50 mM
NaF and 20 mM sodium pyrophosphate). Cytoskeleton proteins
were washed twice in the same buffer and extracted with the
buffer containing 1 M NaCl. The resulting material was dissol-
ved with 6 M urea for 1 h on ice and subjected to SDS/PAGE
as described above. The proteins were transferred to PVDF
membrane (Bio-Rad, Hercules, CA, U.S.A.), blocked with PBS
containing 5% skimmed milk and incubated with a mouse mAb
anti-phosphoserine (Sigma) diluted in PBS/5% skimmed milk,
for 1 h at room temperature. After several washes in PBS con-
taining 0.05% Tween 20 the membrane was incubated with anti-
mouse IgG conjugated to peroxidase and developed as described
above.
Transmission electron microscopy
Parasite suspensions were fixed in 3% (v/v) glutaraldehyde
buffered with 0.1 M sodium cacodylate, pH 7.2, for 48 h at room
temperature (20 ◦C). The fixed trypanosomes were centrifuged
(1000 g) for 30 s, and the supernatant was removed. The pellet
was resuspended in previously warm (45 ◦C) 0.1 M sodium
cacodylate, pH 7.2, containing 2% (w/v) agar and allowed to cool
to room temperature. All subsequent procedures employed cold
(4 ◦C) solutions through 95% ethanol; 100% ethanol and pro-
pylene oxide were used at room temperature. The solidified
agar was cut into small cubes (1–2 mm3) and fixed for 24 h in
PBS/2.5% glutaraldehyde. The agar cubes were rinsed several
times in PBS and then post-fixed in PBS/1% (w/v) osmium
tetroxide for 4 h. The cubes were subsequently rinsed in PBS,
dehydrated through a graded ethanol series, treated with propylene
oxide (transitional fluid) and embedded in resin Embed 812. Thin
sections were obtained with a Sorvall MT-II microtome and
placed on copper grids. Samples were stained with 4% uranyl
acetate in methanol and lead citrate, and examined in a Philips
Tecnai 12 Bio Twin transmission electron microscope operated at
80 kV.
Scanning electron microscopy
Parasite suspensions were spread on acid-washed 18-mm-
diameter circular coverslips and partially air-dried. The coverslips
were placed in 2.5% (v/v) glutaraldehyde buffered with 0.1 M
sodium cacodylate (pH 7.2) for 12 h at 4 ◦C, rinsed several
times in PBS, post-fixed in PBS/1% (v/v) osmium tetroxide for
2 h, rinsed several times in PBS, and dehydrated in a graded
ethanol series. The coverslips were then placed in acetone and
critical-point dried from liquid CO2 in a Tousimis Samdri-
790 critical-point drier (Tousimis Research Corp., Rockville,
MD, U.S.A.). Coverslips were mounted on scanning electron
microscopy aluminium stubs with silver paint and sputter coated
in a Denton Du-502 vacuum evaporator (Denton Vacuum, Cherry
Hill, NJ, U.S.A.) equipped with a gold target. The critical-point-
dried and sputter-coated trypanosomes were then examined on
a Super IIIA or an SS-40 scanning electron microscope (ISI
International Scientific Instruments, Santa Clara, CA, U.S.A.)
operated at 15 kV.
Isolation of nucleic acids: Northern- and Southern-blot
hybridizations
Epimastigotes (4 ×109 cells) were lysed in 10 mM Tris/HCl,
pH 8.0, containing 100 mM EDTA, 0.5% SDS, 20 µg/ml RNase
and 100 µg/ml proteinase K for 3 h at 50 ◦C. After phenol/
chloroform extraction, the DNA was precipitated with 0.2 vol.
of 10 M ammonium acetate and 2 vol. of ethanol. Total RNA
from epimastigotes, tissue-culture trypomastigotes, metacyclic
trypomastigotes and in vitro-transformed amastigotes were
isolated with Trizol (Gibco-BRL, Gaithersburg, MD, U.S.A.)
according to the manufacturer’s instructions.
Total RNA (12 µg), isolated from different developmental
stages of T. cruzi, was electrophoresed on 1% agarose/
formaldehyde gels and blotted on to nylon Hybond N membranes
(Amersham Biosciences) using a vacuum blotter (Bio-Rad).
Hybridization was performed overnight at 42 ◦C in a solution con-
taining 50% formamide and 5 × SSC (where 1× SSC is 0.15 M
NaCl/0.015 M sodium citrate); then the membranes were washed
once with 1 × SSC/0.5% SDS for 20 min at room temperature
and then three times with 0.2 × SSC/0.5% SDS for 20 min each
time at 65 ◦C. Epimastigote genomic DNA was digested with
restriction endonucleases, separated by electrophoresis in a 0.8%
agarose gel, transferred to nylon membrane and hybridized as
described for Northern blots.
Chromosome-sized DNA molecules were prepared in agarose
blocks and stored at 4 ◦C in 0.5 M EDTA, pH 8.0 [27]. Aliquots
of 107 parasites were electrophoresed in 1.2% agarose gel in
0.5 × TBE (45 mM Tris, 45 mM boric acid and 1 mM EDTA,
pH 8.3) at 80 V for 132 h at 13 ◦C, with pulse times varying
from 90 to 800 s, using a Gene Navigator apparatus (Amersham
Biosciences) with a hexagonal electrode [27]. Chromosomal DNA
bands were transferred to nylon membranes and hybridized as
described previously [27].
Cloning of the PP2A gene
Based on amino acid sequences obtained by MS analysis, two
degenerate oligonucleotide primers corresponding to conserved
domains in PP2A were synthesized (Biosynthesis, Lewisville,
TX, U.S.A.). The primers were YGSVNVW (Forward) (5′-
TAYGGNAGTGTNAAYGTNTGG-3′) and LFEAAPD (Reverse)
(5′-GCRTCNGGNGCNGCYTCRAAN-3′). The PCR mixture
(50 µl) contained 1 µg of sheared T. cruzi genomic DNA,
120 pmol of each primer and 2.5 units of Taq polymerase (Invit-
rogen, Carlsbad, CA, U.S.A.). PCR conditions were five cycles
of 95 ◦C for 4 min, 95 ◦C for 1 min, 40 ◦C for 1 min and 72 ◦C
for 1.5 min, then 35 cycles of 95 ◦C for 1 min, 45 ◦C for 1 min
and 72 ◦C for 1.5 min, followed by 95 ◦C for 1 min and 72 ◦C
c© 2003 Biochemical Society
650 J. Gonza´lez and others
for 7 min in a PTC 100 Programmable Thermal Controller (MJ
Research, Watertown, MA, U.S.A.). The PCR product of the
expected size (522 bp) was isolated and cloned using a Topo TA
Kit (Invitrogen, Carlsbad, CA, U.S.A.). Sequencing of cloned in-
serts was performed using the PRISM Ready Reaction DyeDeoxy
Terminator Cycle Sequencing Kit (Perkin-Elmer, Wellesley, MA,
U.S.A.) in an Applied Biosystems model 377 DNA automatic
sequencer (Foster City, CA, U.S.A.).
PP2A gene was also isolated from a T. cruzi cDNA library
constructed in vector pCMV-SPORT 6 (Gibco-BRL) using
poly(A)+ mRNA from metacyclic trypomastigotes according to
the manufacturer’s instructions. The library was screened with
a 32P-labelled 522-bp PP2A amplicon described above, and the
positive clones were purified and sequenced.
PP assay
PP2A activities of T. cruzi native or recombinant PP2A were
determined by using a 32P-labelled phosphorylase a assay system
(Invitrogen Life Technologies, Carlsbad, CA, U.S.A.) according
to the manufacturer’s instructions. Cell extracts were prepared
as described previously [12]. DH5-α Escherichia coli lysate
samples were serially diluted 2-fold in 50 mM imidazole, pH 7.0,
containing 2 mM MnCl2, 1 mM EDTA, 2 mM dithiothreitol and
1% Triton X-100 prior to assay. One unit of phosphatase activity
is defined as the amount that releases 1 nmol of [32P]Pi from 32P-
labelled phosphorylase a/min. The concentrations of okadaic acid
and calyculin A in the assay mixture ranged from 0 to 1 µM.
RESULTS
Effect of okadaic acid on T. cruzi trypomastigote transformation
Trypomastigotes were incubated in the presence of different
concentrations of genistein, staurosporine, herbimycin A, api-
genin and okadaic acid, and their transformation into amastigotes
assessed by light microscopy. Among the different kinase and
PP inhibitors tested, only okadaic acid, a serine/threonine PP
inhibitor, inhibited T. cruzi transformation. When the effect of
different phosphatase inhibitors was evaluated at 10 µM, only
okadaic acid and calyculin A prevented transformation. On the
other hand, tautomycin, a powerful inhibitor of PP1, blocked
50% of the transformation (Figure 1a). In order to investigate
whether PP1 or PP2A were involved in transformation of try-
pomastigotes into amastigotes, we performed the transformation
assay at pH 5.0 in the presence or absence of okadaic acid and
tautomycin (Figure 1b). Even at low concentrations (0.1 µM)
okadaic acid had a profound effect on the transformation of
trypomastigotes. In contrast, tautomycin at concentrations up to
10 µM had moderate effect on parasite transformation. Moreover,
1-norokadaone, the cell-permeable inactive analogue of okadaic
acid, did not affect transformation (Figure 1). In mammalian
cells, okadaic acid is a potent PP2A inhibitor (the 50% inhibitory
concentration, IC50, is 2 nM), whereas higher concentrations are
necessary for PP1 (IC50, 60–200 nM) or PP2B (IC50, 10 mM) in-
hibition. PP2C is unaffected by okadaic acid. In contrast, calyculin
A inhibits both PP1 and PP2A, but not PP2B or PP2C, with high
potency (IC50, 0.5–1 nM). Tautomycin is a potent inhibitor of PP1
(IC50, 1 mM) and 10-times-higher concentrations are necessary
to inhibit PP2A (IC50, 10 nM), whereas PP2B is weakly inhibited
and PP2C is unaffected by this compound. These results suggest
that PP2A-type enzymes are involved in parasite transformation.
It should be stressed that during all incubations the parasites
remained fully motile, indicating that okadaic acid is not toxic
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Figure 1 Effect of PP inhibitors on transformation of T. cruzi
trypomastigotes into amastigotes
Parasites were incubated at 37 ◦C for 4 h in the transformation medium alone (Control)
or containing 10 µM of the following phosphatase inhibitors: okadaic acid (OA), calyculin A
(CaA), tautomycin (Tau), cyclophosphamide (Cyc) or 1-norokadaone (1-NO) (a); or 0.1–10 µM
okadaic acid, tautomycin or 1-norokadaone (b). Transformation was scored in a double-blind
fashion by light microscopy, and results expressed as means +− S.D. from three independent
experiments.
for the parasite. No effect or biological role had been described
previously for PP2A in parasites.
The morphological changes induced by exposure of parasites
to okadaic acid (0.1 µM) were confirmed by scanning and trans-
mission electron microscopy. Amastigotes derived from untrea-
ted trypomastigotes showed a characteristic slightly elongated
form (Figure 2a) whereas okadaic acid-treated trypomastigotes,
although not fully transformed, displayed an unusual morphology
with posterior ends exhibiting considerable circularization
(Figure 2b, arrows). Electron microscopy reveals that a typi-
cal amastigote structure was observed in untreated parasites
(Figure 2c). However, okadaic acid treatment of trypomastigotes
inhibited the reshaping of the kinetoplast and cells retained
the flagellum and a characteristic basket-like appearance
(Figure 2d). These results suggested that okadaic acid did not
completely abolish all the steps required for transformation of
trypomastigotes, but apparently arrested the process at an early
stage.
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Figure 2 Scanning and transmission electron microscopic analysis of okadaic acid-treated and untreated T. cruzi after 4 h of incubation in DMEM at pH 5.0
Scanning electron microscopy of amastigotes obtained after differentiation of untreated trypomastigotes (a); okadaic-acid treated trypomastigotes that did not complete the transformation into
amastigotes, showing rounded posterior ends (arrows; b). Transmission electron microscopy of amastigotes obtained from the transformation of untreated trypomastigotes, showed the characteristic
amastigote rod-shaped kinetoplast (c), whereas treated trypomastigotes retained the round kinetoplast morphology (d). Scale bars: (a) and (b), 500 nm; (c) and (d), 10 µm. N, nucleolus; F, flagellum;
K, kinetoplast.
Cytoskeletal proteins of flagellar fraction are dephosphorylated
during transformation
Figure 3(a) shows a Western blot of cytoskeletal proteins
corresponding to the flagellar fraction stained with an anti-
phosphoserine mAb. Although some proteins were phospho-
rylated at serine residues at pH 7.2, at least one polypeptide of
around 60 kDa was phosphorylated soon after acidification.
Furthermore, after 2 or 3 h of incubation at pH 5.0, polypeptides
of 70 and 90 kDa were dephosphorylated. When experiments
were performed in the presence of okadaic acid, all proteins re-
mained phosphorylated, suggesting that phosphorylation and
dephosphorylation processes occur during transformation and that
serine/threonine phosphatases could be involved (Figure 3b). The
inactive analogue of okadaic acid, 1-norokadaone, did not display
any effect, as expected (results not shown).
Identification of okadaic acid target in T. cruzi
We used two approaches to identify the target of okadaic acid
in T. cruzi. First, the native PP2A was isolated from T. cruzi
epimastigotes by affinity chromatography on microcystin–
Sepharose beads. This method is based on the observation that
the cyanobacterial toxin microcystin covalently binds to Cys-273
on PP1 [28]. According to several reports, microcystin has been
shown to be completely selective for the catalytic subunits of PP1
and PP2A. Furthermore, stringent column-washing conditions
were employed throughout (1 M NaCl) to prevent non-specific
ionic and hydrophobic interactions prior to elution. The eluted
fractions were submitted to SDS/PAGE and four major bands of
approx 34, 38, 45 and 55 kDa were identified (Figure 4). The major
Figure 3 Phospho-immunoblot of T. cruzi trypomastigotes
Parasites were incubated in DMEM (pH 5.0) in the absence (a) or presence (b) of okadaic
acid. Aliquots were collected at different time points between 0 and 4 h, lysed and submitted
to SDS/PAGE. Proteins were transferred to PVDF membrane, incubated with a mAb against
phosphoserine and developed by ECL. Molecular-mass standards are shown on the left.
bands were excised from the gel and subjected to MS using Q-TOF
analysis. Four peptides (YGSVNVWR, QITQVYGFYDECLR,
LFEAAPDDA and SHQLVMEGYK) derived from the 34-kDa
band shared high similarity with the catalytic domain of phos-
phoprotein phosphatase 2A (EC 3.1.3.16) of Trypanosoma brucei
c© 2003 Biochemical Society
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Figure 4 Purification of T. cruzi PP2A by microcystin–Sepharose affinity
chromatography
Epimastigote extracts were incubated for 4 h at 4 ◦C with microcystin–Sepharose beads. Bound
proteins were eluted with 3 M KSCN, submitted to SDS/PAGE and silver stained (lane 1). The
major bands were identified by MS analysis. M.W., molecular-mass markers.
Figure 5 Phosphatase activity of native T. cruzi PP2A
(a) Affinity-purified TcPP2A was electrophoresed, blotted on to PVDF and revealed with an
unrelated mAb 25A10 (lane 1) or a mAb raised against human PP2Ac (lane 2). (b) TcPP2A
was immunoprecipitated with mAb against human PP2Ac and phosphatase activity against
32P-labelled phosphorylase was assayed in the absence or presence of different concentrations
of inhibitors and the inactive analogue 1-norokadaone. No phosphatase activity was detected
when native enzyme was immunoprecipitated with an unrelated antibody.
[29]. The peptides obtained from the bands of 55, 45 and 43 kDa
showed sequence similarity with α-tubulin, myosin and actin,
respectively.
In order to demostrate that mAb raised against human PP2Ac
recognizes the T. cruzi PP2A (TcPP2A), a Western blot was
performed. The affinity-purified enzyme was recognized by
the mAb as a single band of 34 kDa, but not by the un-
related mAb 25A10 (Figure 5a). Secondly, PP2A activity was
immunoprecipitated from the affinity-purified material using a
mAb raised against the catalytic region of human PP2A. Then
immunoprecipitates were assayed for PP activity using 32P-
labelled phosphorylase a as a substrate. The PP2A activity was
inhibited in a concentration-dependent manner by okadaic acid
with an estimated IC50 of approx. 2 nM. The IC50 for inhibition
of phosphatase activity by calyculin was approx. 100 nM. On
the other hand, tautomycin only inhibited 20% of the phos-
phorylase a activity, and 1-norokadaone was completely inactive
(Figure 5b).
Identification and characterization of genes encoding PP2A
of T. cruzi
T. cruzi genomic fragments encoding PP2Ac were amplified by
PCR using degenerate primers derived from the amino acid
sequences (YGSVNVWR and LFEAAPD) of native PP obtained
by MS. Amplification of genomic DNA with these primers gave
rise to a 522-bp fragment, the size expected based on PP2A gene
sequences from other organisms. The amplified fragment was
cloned and the similarity of its amino acid sequence to catalytic
subunits of PP2A was confirmed by BLASTN and BLASTP
searches.
In order to isolate an entire copy of the PP2A gene, the 522-
bp fragment was used as a probe to screen a trypomastigote
cDNA library. Five clones were identified and one of them, named
TcPP2A, was sequenced fully. The nucleotide sequence revealed
an open reading frame starting at nucleotide 58 with a methio-
nine codon and ending at nucleotide 966 with a TAG termination
codon. The open reading frame encodes a 303-amino-acid poly-
peptide with a predicted molecular mass of 34.5 kDa, which is
in agreement with the molecular masses of the native PP2A. The
deduced amino acid sequence revealed that the consensus motifs
VGDIH, GDYVDR, LRGNHE and SAPNYC, characteristic of
serine/threonine PPs, are present in the catalytic region of the
polypeptide coded by cDNA TcPP2A. In the same manner,
the peptide sequences YGSVNVWR, QITQVYGFYDECLR,
LFEAAPDDA and SHQLVMEGYK, obtained by MS, were
also found in the peptide coded by PP2A cDNA. This finding
strongly suggests that the product of the PP2A gene is the target
of okadaic acid in the parasite. A BLASTP search [30] against
sequences in the GenBank® database revealed a high identity (53–
86%) with type 2A serine/threonine PPs from different species
(Figure 6a). A high level of identity was observed with PP2A
from T. brucei (86%) and Arabidopsis thaliana (61%), whereas
Homo sapiens, Drosophila melanogaster and Saccharomyces
cerevisiae displayed a lesser degree of identity (53–54%). A
phylogenetic tree was constructed with seven PP2Acs (Figure 6b).
The phenogram indicates the existence of two groups: one major
group corresponding to many different eukaryotic organisms
including human, and another group that comprises the PP2A
of T. brucei and T. cruzi.
Genomic organization and transcription of PP2A genes
When genomic DNA was analysed by Southern blotting using
the PP2A gene as a probe, a very simple hybridization profile was
observed in each lane indicating the presence of a few copies of the
PP2A gene (Figure 7a). Digestion with several enzymes (EcoRI,
HindIII and SacI) that do not cut within the PP2A gene produced
two bands indicating the presence of two copies of this gene.
Consistent with this, Southern-blot analysis of chromosomal DNA
separated by pulsed-field gel electrophoresis (PFGE) revealed that
PP2A genes were present in two chromosomal bands of 2.03 and
1.60 Mb (Figure 7b). These bands hybridized to the PP2A gene
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Figure 6 Sequence alignment of TcPP2A with different eukaryotic PP2A
(a) Comparison of T. cruzi PP2A (GenBank accession no. AY158228) with PPs from T. brucei (M74168), A. thaliana (AF030290), C. elegans (AB070573), D. melanogaster (NM 057457), S.
cerevisiae (NC 001136) and H. sapiens (AF444006). Conserved residues are shaded in light grey (100 % conservation), dark grey ( 75 % conservation) and black ( 50 % conservation) and no
shading denotes residues with < 50 % conservation. The four conserved motifs found in all members of the PPP family are underlined. (b) Sequence alignment and phenogram construction were
performed using the Clustal method from LaserGene software. Numbers represent the percentage divergence.
probe with the same intensities, suggesting that they carry the
same number of copies of the PP2A gene.
The steady-state level of PP2A transcripts in the T. cruzi
developmental stages was determined by Northern-blot hybrid-
ization using the 32P-labelled fragment of 522 bp as a probe. It
hybridized with a major 2.1-kb mRNA that is present in all stages,
suggesting that the PP2A gene is constitutively transcribed.
Densitometric scanning analysis of the ethidium bromide-stained
c© 2003 Biochemical Society
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Figure 7 Genomic organization of T. cruzi PP2A genes
(a) Southern-blot hybridization of genomic DNA. Genomic DNA (4 µg) was digested with the
indicated restriction enzymes, electrophoresed in agarose gel, transferred to nylon membrane
and hybridized to the T. cruzi PP2A gene probe. (b) Chromoblot hybridization. Chromosomal
bands of epimastigotes were separated by PFGE, stained with ethidium bromide (lane 1),
transferred to nylon membrane and hybridized with the same probe described above (lane 2).
Standard size markers are in kb or Mb.
agarose gel and hybridization with the β-tubulin probe indicated
that each lane carried equivalent amounts of RNA (results not
shown).
DISCUSSION
PP2A is an important component of major regulatory pathways
in higher eukaryotes, controlling a wide range of intracellular
processes [5,6,14]. Although PP2A has been demonstrated in a
broad range of organisms, including protozoan parasites like T.
brucei [29] and Plasmodium falciparum [31], the enzyme had
not yet been identified in T. cruzi. Even more, according to
Orr et al. [12], no phosphoserine/threonine phosphatase gene
other than the PP1 gene had been amplified from T. cruzi
genomic DNA when the universal PP1/PP2A/PP2B primers
were used in PCR amplification. They suggested that PP2A-
/PP2B-type phosphatases could not exist in this lower-eukaryotic
protozoan. However, in this paper we provide conclusive evidence
for a critical role for PP2A in the transformation of T. cruzi.
Furthermore, the PP2A protein was identified and the corre-
sponding gene was cloned and characterized.
The availability of highly specific inhibitors of PP1 and PP2A
[32,33] has provided useful tools to investigate the role of PP2A in
the transformation of T. cruzi. The pattern of sensitivity to these
compounds suggests strongly that PP2A-type enzymes were
involved in parasite transformation. In T . brucei, okadaic acid
has been used to uncouple nucleus and kinetoplast segregation
[34]. In the presence of this drug the kinetoplast DNA was able
to replicate but segregation and formation of new organelles
were inhibited. Moreover, flagellar duplication was incomplete
and the organisms retained their elongated morphology. In
contrast, T. cruzi trypomastigotes are not replicative forms, and
consequently neither organelle segregation nor flagellar duplic-
ation occurs in this stage. However, the fact that okadaic acid-
treated trypanosomes did not appear to retain their shape after
treatment suggests a common role for PP2A in trypanosome trans-
formation.
Microcystin–Sepharose chromatography in association with
MS analysis allowed us to identify a 34-kDa band corresponding
to T. cruzi PP2A with three additional bands corresponding to
myosin, actin and α-tubulin (Figure 4). According to previous
reports using several cell types, microcystin was completely
selective for the catalytic subunits of PP1 and PP2A. Therefore
only these proteins and their associated regulatory subunits should
be recovered by this approach [35,36]. However, we believe that
the identification of proteins other than phosphatases was not
fortuitous, because the contamination of the preparation with these
proteins could be ruled out due to the high stringency of washing
conditions employed before the elution of proteins specifically
bound to the column. In fact, actin, myosin and α-tubulin have
been identified previously as components of the T. cruzi cyto-
skeleton [37,38]. Then our findings strongly suggest that T. cruzi
PP2A could be associated with the parasite cytoskeleton as
has been shown in other cell types [39,40]. This possibility
makes sense if we consider that, in mammalian cells, protein
phosphorylation/dephosphorylation is an essential regulatory
mechanism for maintaining the functionality of the cytoskeleton
[41,42]. In another flagellate, it has been reported that PP1 and
PP2A are located in distinct positions in the Chlamydomonas
flagellar axoneme [43]. We could then speculate that PP2A par-
ticipates in the transformation of T. cruzi regulating microtubule
stability. Considering that okadaic acid-treated trypomastigotes
maintained the elongated form and that its flagellum remained
after incubation in DMEM at pH 5.0 for 4 h, we could ima-
gine that transformation requires dephosphorylation of some
unidentified protein(s). After dephosphorylation, the flagellar
proteins are degraded and the parasite finally reaches the typi-
cal round form. The observations that flagellar proteins are phos-
phorylated and dephosphorylated during transformation, and that
dephosphorylation is inhibited by okadaic acid but not by 1-
norokadaone, come to support this hypothesis (Figure 3). To
demostrate this hypothesis, PP activity was co-immunprecipitated
with T. cruzi cytoskeletal proteins using mAbs raised against
α-tubulin, actin and myosin. This activity was inhibited between
30 and 50% by okadaic acid but not by tautomycin or 1-
norokadaone (results not shown). These results strongly suggest
that PP2A among other PPs could be physically associated with
the parasite cytoskeleton.
Although the T. cruzi PP2A enzyme was isolated and char-
acterized, the PP2A target(s) and molecular mechanism where
this signal component is involved remains elusive. A role for
phosphorylation cascade in the transformation of trypomastigotes
into amastigotes has been postulated [44]. In fact, calyculin A,
a potent inhibitor of PP1A and PP2A, induced transformation
of T. cruzi trypomastigotes into amastigotes at pH 7.5 [45].
According to these authors, an exposure of trypomastigotes
to calyculin A concentrations as low as 1 nM for only 1–2 h
was sufficient to induce transformation. However, in a different
experiment, where trypomastigotes were pre-incubated with
okadaic acid or calyculin A for 60–90 min at 37 ◦C in DMEM,
pH 7.4, we were unable to detect any parasite transformation.
The reasons for the differences from the observations reported by
Grellier et al. [44] are not clear. Considering that these authors
have worked with different T. cruzi strains, we could speculate
that strain-dependent signal transduction pathways could be
involved in T. cruzi transformation. On the other hand, activation
of the inositol phosphate/diacylglycerol signalling cascade by
acidic conditions could have an important role in the T. cruzi
differentiation process [45].
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The T. cruzi PP2A gene shares a high level of homology with
T. brucei PP2A (86%). When T. cruzi PP2A was compared
with the enzyme from different organisms, it was found that
the level of identity ranged from 53 to 86% (Figure 6a). In
addition, four conserved structural motifs from the catalytic
domain, GDXHG, GDXVXRG, GNH and SAPNYC, found in
all PPP proteins examined thus far [16,29,46], are also present
in trypanosome phosphatases as well as in PP2A described here.
The amino acid sequence also reveals the presence of the
LFEAAPDD motif that appears to be unique for trypanosomes,
considering that is also present in T. brucei and appears less
conserved or even absent in other species. On the other hand,
the sequence YGSVNVW that is highly conserved in the PP2A
catalytic site and absent in PP1 was present in T. cruzi
PP2A (Figure 6a).
The C-terminal sequence PDYFL of the PP2Ac subunit is
completely conserved among mammals, yeast, fruit flies and
plants, suggesting that regulation of this enzyme activity by
C-terminal methylation has been conserved throughout evolution.
A methylation motif is also present in T. cruzi PP2A, but it
contained aspartic instead of glutamic acid (Figure 6a). The sig-
nificance of this modification is not clear but considering that
glutamic and aspartic acids are negatively charged amino acids,
we could speculate that the structural and functional features of
the enzyme should remain intact.
The alignment and phenogram analyses showed that this
enzyme shares extraordinary amino acid similarity with those
from T. brucei, suggesting an evolutionary link via a common
ancestor gene. On the other hand, the degree in sequence identity
between trypanosomal and mammalian phosphatases is remark-
able even considering the early divergence of the trypanosomatids
from the main branch of the eukaryotic lineage. Thus it seems
reasonable to believe that conserved domains between trypano-
somal and higher-eukaryotic PP2Ac should be relevant from
a functional point of view (Figure 6b).
Southern-blot hybridizations suggest that PP2A genes are
present in at least two copies per genome (Figure 7a). PP2A genes
were mapped in two chromosomal bands separated by PFGE in
the G and CL strains, confirming the presence of two copies of the
PP2A gene (Figure 7b). Gene cloning has revealed the existence
of two PP2A isoforms in mammals [47], whereas in Drosophila
[48] and T. brucei [29] a single PP2A gene was found.
Native PP2A was shown to catalyse the dephosphorylation of
32P-labelled phosphorylase a and exhibited inhibitor sensitivities
similar to those of its mammalian counterpart. Considering that
the native protein has at least four amino acid motifs that are also
present in the deduced amino acid sequence of the isolated gene,
we can conclude that the actual target of okadaic acid during
T. cruzi transformation is PP2A.
Taken together, our results are consistent with the presence of
a PP2A in T. cruzi that is involved in parasite transformation.
The enzyme displays high homology with T. brucei PP2A but
less significant homology with the human enzyme. These findings
open new possibilities for the rational design of chemotherapeutic
agents to control Chagas’ disease and T. cruzi PP2A could be
considered as a new target, especially because of the differences
from its human counterpart. This possibility becomes even more
attractive in view of the fact that other signal components like
protein kinases have already been proposed as drug targets in
parasitic protozoa [49].
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